BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23278711)

  • 1. Predicting late recurrence in surgically treated patients with Cushing's disease.
    Barbot M; Albiger N; Koutroumpi S; Ceccato F; Frigo AC; Manara R; Fassina A; Gardiman MP; Scanarini M; Mantero F; Scaroni C
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):394-401. PubMed ID: 23278711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.
    Tsagarakis S; Vassiliadi D; Kaskarelis IS; Komninos J; Souvatzoglou E; Thalassinos N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2080-6. PubMed ID: 17356045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison.
    Le Marc'hadour P; Muller M; Albarel F; Coulon AL; Morange I; Martinie M; Gay E; Graillon T; Dufour H; Conte-Devolx B; Chabre O; Brue T; Castinetti F
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):216-22. PubMed ID: 25660243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test.
    Dall'Asta C; Barbetta L; Bonavina L; Beck-Peccoz P; Ambrosi B
    Pituitary; 2004; 7(3):183-188. PubMed ID: 16328567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical predictors of outcome of pituitary surgery for Cushing's disease.
    Alwani RA; de Herder WW; van Aken MO; van den Berge JH; Delwel EJ; Dallenga AH; De Jong FH; Lamberts SW; van der Lely AJ; Feelders RA
    Neuroendocrinology; 2010; 91(2):169-78. PubMed ID: 19907141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The desmopressin test in the diagnosis of Cushing's disease].
    Gasińiska T; Dec R; Wichary H; Pietrasik L; Kulawik G
    Pol Arch Med Wewn; 2007; 117(1-2):20-6. PubMed ID: 17642202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing's Disease.
    Vassiliadi DA; Balomenaki M; Asimakopoulou A; Botoula E; Tzanela M; Tsagarakis S
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4878-4885. PubMed ID: 27662440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.
    Tsagarakis S; Tsigos C; Vasiliou V; Tsiotra P; Kaskarelis J; Sotiropoulou C; Raptis SA; Thalassinos N
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test.
    Ritzel K; Beuschlein F; Berr C; Osswald A; Reisch N; Bidlingmaier M; Schneider H; Honegger J; Geyer LL; Schopohl J; Reincke M
    Eur J Endocrinol; 2015 Aug; 173(2):197-204. PubMed ID: 25953828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Barbot M; Trementino L; Zilio M; Ceccato F; Albiger N; Daniele A; Frigo AC; Mardari R; Rolma G; Boscaro M; Arnaldi G; Scaroni C
    Pituitary; 2016 Oct; 19(5):488-95. PubMed ID: 27236452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease.
    Castinetti F; Martinie M; Morange I; Dufour H; Sturm N; Passagia JG; Conte-Devolx B; Chabre O; Brue T
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1897-903. PubMed ID: 19276234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state: a comparative study.
    Tirabassi G; Papa R; Faloia E; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):666-72. PubMed ID: 21554373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease.
    Romanholi DJ; Machado MC; Pereira CC; Danilovic DS; Pereira MA; Cescato VA; Cunha Neto MB; Musolino NR; de Mendonça BB; Salgado LR
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):117-22. PubMed ID: 18182093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease.
    Losa M; Bianchi R; Barzaghi R; Giovanelli M; Mortini P
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3322-8. PubMed ID: 19584185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild?
    Ragonese M; Cotta OR; Ferraù F; Trimarchi F; Cannavò S
    Gynecol Endocrinol; 2012 Aug; 28(8):637-9. PubMed ID: 22309603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma corticotrophin response to desmopressin in patients with Cushing's disease correlates with the expression of vasopressin receptor 2, but not with that of vasopressin receptor 1 or 3, in their pituitary tumours.
    Wang FF; Tang KT; Yen YS; Ho DM; Yang AH; Huang CI; Lin HD; Won JG
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):253-63. PubMed ID: 21781143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's disease: predicting long-term remission after surgical treatment.
    Pendharkar AV; Sussman ES; Ho AL; Hayden Gephart MG; Katznelson L
    Neurosurg Focus; 2015 Feb; 38(2):E13. PubMed ID: 25639315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.